Evidence map›Paper›PMID 11717455›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung.

J F Poschet, J C Boucher, L Tatterson, J Skidmore, R W Van Dyke, V Deretic

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 87 citations in OpenAlex.

  1. ATG16L1 controls mammalian vacuolar proton ATPase.The Journal of cell biology · 2025
    Article
  2. Review
  3. Article
  4. Review
  5. The Golgi as a "Proton Sink" in Cancer.Frontiers in cell and developmental biology · 2021
    Article
  6. Article
  7. Golgi pH, Ion and Redox Homeostasis: How Much Do They Really Matter?Frontiers in cell and developmental biology · 2019
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Specificity in cancer immunotherapy.Seminars in immunology · 2008
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

J F PoschetDepartment of Microbiology and Immunology University of Michigan Medical School, Ann Arbor, MI 48109, USA.
J C Boucher
L Tatterson
J Skidmore
R W Van Dyke
V Deretic
University of Michigan–Ann Arbor · USUniversity of New Mexico · US

Funding

PSEUDOMONAS IN CYSTIC FIBROSIS--REGULATION OF MUCOIDYR01AI031139 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI DERETIC, VOJO P · 1992 to 2006
$2.5M
NIAID NIH HHS AI31139NIAID NIH HHS R01 AI031139
6 · The paper itself

Abstract

The CFTR gene encodes a transmembrane conductance regulator, which is dysfunctional in patients with cystic fibrosis (CF). The mechanism by which defective CFTR (CF transmembrane conductance regulator) leads to undersialylation of plasma membrane glycoconjugates, which in turn promote lung pathology and colonization with Pseudomonas aeruginosa causing lethal bacterial infections in CF, is not known. Here we show by ratiometric imaging with lumenally exposed pH-sensitive green fluorescent protein that dysfunctional CFTR leads to hyperacidification of the trans-Golgi network (TGN) in CF lung epithelial cells. The hyperacidification of TGN, glycosylation defect of plasma membrane glycoconjugates, and increased P. aeruginosa adherence were corrected by incubating CF respiratory epithelial cells with weak bases. Studies with pharmacological agents indicated a role for sodium conductance, modulated by CFTR regulatory function, in determining the pH of TGN. These studies demonstrate the molecular basis for defective glycosylation of lung epithelial cells and bacterial pathogenesis in CF, and suggest a cure by normalizing the pH of intracellular compartments.

Indexed as

GlycoproteinsMembrane ProteinsAcidsBacterial AdhesionCell LineCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorGlycosylationGreen Fluorescent ProteinsHumansLuminescent ProteinsLungMembrane GlycoproteinsProton-Translocating ATPasesPseudomonas aeruginosaRecombinant Fusion ProteinsAcidsCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorGlycoproteinsGreen Fluorescent ProteinsLuminescent ProteinsMembrane GlycoproteinsMembrane ProteinsProton-Translocating ATPasesRecombinant Fusion ProteinsSialyltransferasesSodium-Potassium-Exchanging ATPaseTGOLN2 protein, human

Identifiers

PMID11717455
PMCPMC61151
OpenAlexW1978183357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.